ArticleCancer science2008

Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.

Akiko Horiuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.